Strategic Partnerships To Accelerate ChemT Bio’s Growth

Written By Jie Sun

At ChemT Bio, collaboration is at the heart of innovation. We’re thrilled to announce partnerships with Memorial Sloan Kettering Cancer Center and Cytiva, two titans in healthcare and biologics manufacturing. These collaborations validate our AI-driven approach to solving critical bottlenecks in cell therapy production.

  • Memorial Sloan Kettering is piloting Chemplify to reduce CAR-T manufacturing timelines from 14 days to 7, aiming to expand patient access to life-saving therapies.

  • Cytiva will integrate Chemplify into their CDMO workflows, offering clients a 30–50% cost reduction per dose.

“ChemT Bio’s technology aligns with our mission to industrialize advanced therapies. Their AI-driven small molecules could redefine manufacturing efficiency.”
— Cytiva Representative

These partnerships underscore trust in our platform and pave the way for scalable adoption. Learn how we’re partnering to democratize biologics [here].

Jie Sun
Next

Blog Post Title Two